scholarly article | Q13442814 |
P50 | author | Jun Wan | Q55137372 |
P2093 | author name string | Heng Zhu | |
Jiang Qian | |||
Gary S Hayward | |||
Jian Zhu | |||
Richard F Ambinder | |||
Gangling Liao | |||
S Diane Hayward | |||
Yong Gu Cho | |||
Otoniel Martinez-Maza | |||
Crystal Woodard | |||
Dasheng Zheng | |||
Chuang-Jiun Chiou | |||
Leyao Wang | |||
Shweta Pai | |||
P2860 | cites work | Proteins of purified Epstein-Barr virus | Q37621844 |
Non–AIDS-Defining Malignancies in Patients with HIV in the HAART Era | Q37838813 | ||
Proteome-wide analysis of the serological response to vaccinia and smallpox | Q38432898 | ||
A naturally derived gastric cancer cell line shows latency I Epstein-Barr virus infection closely resembling EBV-associated gastric cancer | Q38518045 | ||
Geographic Heterogeneity of Prevalence of the Human Herpesvirus 8 in Sub-Saharan Africa: Clues About Etiology | Q38871413 | ||
Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis | Q39683622 | ||
Multiple pathways for Epstein-Barr virus episome loss from nasopharyngeal carcinoma | Q39952661 | ||
Infectious mononucleosis. Epstein-Barr-virus shedding in saliva and the oropharynx | Q39986542 | ||
B cell terminal differentiation factor XBP-1 induces reactivation of Kaposi's sarcoma-associated herpesvirus | Q40110061 | ||
Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus | Q40727982 | ||
Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected | Q40962673 | ||
Characterization of a latent protein encoded by the large internal repeats and the BamHI Y fragment of the Epstein-Barr virus (EBV) genome | Q42649422 | ||
No correlation in Epstein-Barr virus reactivation between serological parameters and viral load | Q42726648 | ||
Infectious human herpesvirus 8 in a healthy North American blood donor | Q44132374 | ||
Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription. | Q45398580 | ||
Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma | Q45629039 | ||
Expression of the Epstein-Barr virus (EBV)-encoded latent membrane protein 2A (LMP2A) in EBV-associated nasopharyngeal carcinoma | Q45640598 | ||
Salivary production of IgA and IgG to human herpes virus 8 latent and lytic antigens by patients in whom Kaposi's sarcoma has regressed | Q45653934 | ||
Evidence for concurrent epidemics of human herpesvirus 8 and human immunodeficiency virus type 1 in US homosexual men: rates, risk factors, and relationship to Kaposi's sarcoma | Q45747380 | ||
Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma | Q45750458 | ||
Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors | Q47688207 | ||
Screening for family members of patients with nasopharyngeal carcinoma | Q50751206 | ||
Evaluation of the latency-associated nuclear antigen (ORF73) of Kaposi's sarcoma-associated herpesvirus by peptide mapping and bacterially expressed recombinant western blot assay | Q53909009 | ||
Assessing the risk of nasopharyngeal carcinoma on the basis of EBV antibody spectrum | Q57262055 | ||
Human herpesvirus 8 genomes and seroprevalence in United States blood donors | Q82583545 | ||
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma | Q28284765 | ||
The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output | Q28752465 | ||
KSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation | Q30433391 | ||
Molecular diversity of Epstein-Barr virus IgG and IgA antibody responses in nasopharyngeal carcinoma: a comparison of Indonesian, Chinese, and European subjects | Q31078772 | ||
Combination of Epstein-Barr virus scaffold (BdRF1/VCA-p40) and small capsid protein (BFRF3/VCA-p18) into a single molecule for improved serodiagnosis of acute and malignant EBV-driven disease | Q33629888 | ||
Mucosal shedding of human herpesvirus 8 in men. | Q33924644 | ||
Substantial regional differences in human herpesvirus 8 seroprevalence in sub-Saharan Africa: insights on the origin of the "Kaposi's sarcoma belt" | Q33952679 | ||
Comparison of serologic assays for detection of antibodies against human herpesvirus 8. | Q33999426 | ||
Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCR | Q34340317 | ||
Sexual Transmission and the Natural History of Human Herpesvirus 8 Infection | Q34462040 | ||
Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo | Q34553645 | ||
Severe acute respiratory syndrome diagnostics using a coronavirus protein microarray | Q34572875 | ||
Sensitivity and specificity of Epstein-Barr virus IGA titer in the diagnosis of nasopharyngeal carcinoma: a three-year institutional review. | Q35824288 | ||
Kaposi's sarcoma and its associated herpesvirus | Q36487309 | ||
Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. | Q36637195 | ||
Risk factors for human Herpesvirus 8 infection and AIDS-associated Kaposi's sarcoma among men who have sex with men in a European multicentre study | Q36677160 | ||
Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts | Q36696963 | ||
Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma. | Q36697762 | ||
A bicistronic Epstein-Barr virus mRNA encodes two nuclear proteins in latently infected, growth-transformed lymphocytes | Q36886069 | ||
Epstein-Barr virus: a paradigm for persistent infection - for real and in virtual reality | Q37105232 | ||
Protein array identification of substrates of the Epstein-Barr virus protein kinase BGLF4 | Q37192108 | ||
Effects of chemotherapy in AIDS-associated non-Hodgkin's lymphoma on Kaposi's sarcoma herpesvirus DNA in blood | Q37198986 | ||
Kaposi's sarcoma-associated herpesvirus transmission and primary infection | Q37429716 | ||
U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2 | Q37579511 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Epstein–Barr virus | Q6900 |
P304 | page(s) | 1683-1691 | |
P577 | publication date | 2011-10-11 | |
P1433 | published in | Journal of Infectious Diseases | Q4051141 |
P1476 | title | Comparison of humoral immune responses to Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus using a viral proteome microarray | |
P478 | volume | 204 |
Q28385995 | Application of Proteomics to Soft Tissue Sarcomas |
Q36668535 | Development of Whole-Virus Multiplex Luminex-Based Serological Assays for Diagnosis of Infections with Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8 Homologs in Macaques |
Q39474152 | Domestic cats seropositive for Felis catus gammaherpesvirus 1 are often qPCR negative |
Q27021572 | Epstein-Barr virus antibodies and the risk of associated malignancies: review of the literature |
Q42332100 | FCGR2A and FCGR3A polymorphisms in classical Hodgkin lymphoma by Epstein-Barr virus status. |
Q27025953 | Functional protein microarray as molecular decathlete: a versatile player in clinical proteomics |
Q35133590 | Heterogeneity and breadth of host antibody response to KSHV infection demonstrated by systematic analysis of the KSHV proteome |
Q28297010 | Immunoproteomics: Current Technology and Applications |
Q27026000 | KSHV: pathways to tumorigenesis and persistent infection |
Q35013894 | Luciferase immunoprecipitation systems for measuring antibodies in autoimmune and infectious diseases |
Q97067564 | Network-Based Analysis of OMICs Data to Understand the HIV-Host Interaction |
Q36523994 | ORF33 and ORF38 of Kaposi's Sarcoma-Associated Herpesvirus Interact and Are Required for Optimal Production of Infectious Progeny Viruses |
Q54261416 | Patterns of inter-individual variability in the antibody repertoire targeting proteins across the Epstein-Barr virus proteome. |
Q36791459 | Quantitative determinations of anti-Kaposi sarcoma–associated herpesvirus antibody levels in men who have sex with men |
Q36145066 | Rapid Multiplexed Immunoassay for Detection of Antibodies to Kaposi's Sarcoma-Associated Herpesvirus |
Q33633451 | Recent 5-year Findings and Technological Advances in the Proteomic Study of HIV-associated Disorders |
Q36178032 | The Cancer-Associated Virus Landscape in HIV Patients with Oral Hairy Leukoplakia, Kaposi's Sarcoma, and Non-Hodgkin Lymphoma |
Q45101653 | The antibody response to Epstein–Barr virions is altered in multiple sclerosis |
Search more.